LOADING
Comparing AbbVie Inc (ABBV) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | KO |
|---|---|---|
| Price | $210.77 | $80.45 |
| Change Today | +1.09% | +0.24% |
| Market Cap | $368.4B | $345.3B |
| P/E Ratio | 102.2 | 25.2 |
| Forward P/E | 14.1 | 24.1 |
| PEG Ratio | 0.56 | 4.01 |
| EPS | $2.04 | $3.19 |
| Revenue Growth (YoY) | 12.4% | 12.1% |
| Profit Margin | 5.8% | 27.8% |
| Return on Equity | 62.3% | 43.4% |
| Dividend Yield | 3.24% | 2.57% |
| Beta | 0.30 | 0.36 |
| 52-Week High | $239.13 | $81.44 |
| 52-Week Low | $174.56 | $64.45 |
| Volume | 5.0M | 10.6M |
AbbVie Inc is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.